Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults

Circulation

Volumn 110, Issue 10, 2004, Pages 1245-1250

  Malik, Shaista ^a   Wong, Nathan D ^a,c   Franklin, Stanley S ^a   Kamath, Tripthi V ^b   L'Italien, Gilbert J ^b   Pio, Jose R ^a   Williams, G Rhys ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Diabetes mellitus; Metabolic syndrome X; Mortality; Risk factors

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENDER; HEALTH SURVEY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; UNITED STATES;

ADULT; AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT STUDIES; COMORBIDITY; CORONARY DISEASE; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HEALTH SURVEYS; HUMANS; HYPERLIPIDEMIAS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MORTALITY; OBESITY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 4444222221     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000140677.20606.0E     Document Type: Article

References (24)

1. Haffner SM, Lehto S, Ronnemaa T. et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229-234.
2. Saydah SH, Eberhardt MS, Loria CM, et al. Age and the burden of death attributable to diabetes in the United States. Am J Epidemiol. 2002;156:714-719.
3. Miettinen H, Lehto S, Salomaa V, et al. Impact of diabetes on mortality after the first myocardial infarction: the FINMONICA Myocardial Infarction Register Study Group. Diabetes Care. 1998;21:69-75.
4. Cho E, Rimm EB, Stampfer MJ, et al. The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men. J Am Coll Cardiol. 2002;40:954-960.
5. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
6. Albertti KG, Zimmet PZ. Definition, diagnosis, and classification of diabetes mellitus and its complications 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetes Med. 1998;15:539-553.
7. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
8. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults. JAMA. 2002;287:356-359.
9. Trevisan M, Liu J, Bahsas FB, et al. Syndrome X and mortality: a population-based study. Am J Epidemiol. 1998;148:958-966.
10. Burchfiel CM, Sharp DS, Curb DJ, et al. Hyperinsulinemia and cardiovascular disease in elderly men. Arterioscler Thromb Vasc Biol. 1998;18:450-457.
11. Solymoss BC, Marcil M, Cahour M, et al. Fasting hyperinsulinism, insulin resistance syndrome, and coronary artery disease in men and women. Am J Cardiol. 1995;76:1152-1156.
12. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709-2716.
13. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683-689.
14. Loria CM, Sempos CT, Vuong C. Plan and operation of the NHANES II Mortality Study, 1992. Vital Health Stat. 1999;38:1-16.
15. McDowell A, Engel A, Masey J, et al. National Center for Health Statistics: Plan and Operation of the Second National Health and Nutrition Examination Survey, United States, 1976-1980. Washington, DC: US Government Printing Office; 1981. DHHS publication No. PHS81-1317, Vital and Health Statistics, series 1, No. 15.
16. Wong ND, Pio JR, Franklin SS, et al. Preventing coronary events by optimal control of blood pressure and lipids in patients with the metabolic syndrome. Am J Cardiol. 2003;91:1421-1426.
17. Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383-393.
18. Ninomiya JK L'Italien G, Criqui MH, et al. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation. 2004;109:42-46.
19. Wong ND, Sciammarella M, Miranda-Peals R, et al. The metabolic syndrome: diabetes, and subclinical atherosclerosis assessed by coronary calcium. J Am Coll Cardiol. 2003;41:1547-1553.
20. Janssen I, Katzmarzyk PT, Ross R. Body mass index, waist circumference, and health risk. Arch Intern Med. 2002;162:2074-2079.
21. Park YW, Zhu S, Palaniappan L, et al. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2003;163:427-436.
22. Sattar N, Gaw A, Scherbakova O, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation. 2003;108:414-419.
23. Carnevale Schianca GP, Rossi A, Sainaghi PP, et al. The significance of impaired fasting glucose versus impaired glucose tolerance: importance of insulin secretion and resistance. Diabetes Care. 2003;26:1333-1337.
24. Hanefeld M, Koehler C, Fuecker K, et al. Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the Risk Factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes Study. Diabetes Care. 2003;26:868-874.